Your browser doesn't support javascript.
loading
The Role of PSMA PET Imaging in the Classification of the Risk of Prostate Cancer Patients: A Systematic Review on the Insights to Guide an Active Surveillance Approach.
Dondi, Francesco; Antonelli, Alessandro; Suardi, Nazareno; Treglia, Giorgio; Bertagna, Francesco.
Afiliação
  • Dondi F; Nuclear Medicine, ASST Spedali Civili di Brescia and Università degli Studi di Brescia, 25123 Brescia, Italy.
  • Antonelli A; Department of Urology, Azienda Ospedaliera Universitaria Integrata Verona, University of Verona, 37134 Verona, Italy.
  • Suardi N; Department of Urology, Spedali Civili di Brescia, 25123 Brescia, Italy.
  • Treglia G; Nuclear Medicine, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland.
  • Bertagna F; Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland.
Cancers (Basel) ; 16(6)2024 Mar 11.
Article em En | MEDLINE | ID: mdl-38539457
ABSTRACT

BACKGROUND:

active surveillance (AS) is a suitable strategy for patients with prostate cancer (PCa). Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) imaging is an established tool used to assess PCa. The aim of this review was to evaluate the role of PSMA imaging to guide correct risk-based classification and the AS approach in PCa patients.

METHODS:

The Scopus, Embase, Web of Science, Cochrane Library, and PubMed/MEDLINE databases were screened to find relevant published articles.

RESULTS:

1774 articles were revealed with the literature search. A total of 1764 articles were excluded after applying exclusion criteria (data not within the field of interest, preclinical papers, conference proceedings, reviews, or editorials). Ten studies were finally included in the review, revealing that PSMA PET could have the ability to guide risk-based classification of PCa and the choice of AS, and to guide the execution of biopsies for the research of high-grade PCa, therefore precluding AS.

CONCLUSION:

this systematic review underlined a possible role of PSMA PET imaging in patients with PCa by correctly re-classifying them on the basis of their risk and guiding AS.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2024 Tipo de documento: Article